arrow
K

Kristen M. Sanfilippo

washington university in st louis
H指数:27
被引数:2,726

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis

细胞减灭疗法对骨髓增生性肿瘤相关内脏静脉血栓形成的影响

2026-01-010
OA
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trial

评估爱多沙班与达肝素治疗肿瘤相关性静脉血栓栓塞症的胜率比:一项随机okusai VTE cancer试验的分析

2025-12-190
OAAI
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL

阿糖胞苷治疗急性淋巴细胞白血病患者的静脉血栓栓塞风险预测模型的推导与外部验证

2025-11-010
OAAI
Reduced-Dose Versus Full-Dose Direct Oral Anticoagulants for Extended Secondary Venous Thromboembolism Prophylaxis in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Trials

减量剂量与全剂量直接口服抗凝剂用于癌症患者延长二级静脉血栓栓塞预防:一项随机试验的系统评价和Meta分析

2025-09-240
PRE
Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis

癌症患者中静脉血栓栓塞症复发和出血的预测因素:一项Meta分析

2025-06-011
PRE
Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial (vol 22, pg 1704, 2024)
2025-02-010
PRE
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes

胰高血糖素样肽-1受体激动剂的使用与糖尿病患者中多发性骨髓瘤的不确定意义的单克隆丙种球病进展之间的关系

2024-11-082
OAAI
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
2024-06-0111
PRE